Commentary [Research Highlights : Neurotrophic Factor Treatment of Neurological Disorders: The Benefits of a Pleiotropic Treatment Approach]

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|10|4|415-416

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.4, 2011-06, pp. : 415-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Commentary (Research Highlights: Transcranial Drug Delivery for Neurological Disorders)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 3, 2014-04 ,pp. : 375-376

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary: Neurorestoratology: A Concept and Emerging Discipline in the Treatment of Neurological Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 5, 2016-05 ,pp. : 522-525

Bentham Science Publishers

Access to resources Recommend Favorite

Immunophilin ligands for the treatment of neurological disorders

By Hamilton G.S.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1109-1124

Informa Healthcare

Access to resources Recommend Favorite

Stem Cells for the Treatment of Neurological Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 1, 2008-02 ,pp. : 98-109

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 13, Iss. 3, 2013-09 ,pp. : 166-194

Bentham Science Publishers

Access to resources Recommend Favorite